John L. Higgins

2020

In 2020, John L. Higgins earned a total compensation of $5.8M as Chief Executive Officer at Ligand Pharmaceuticals, a 14% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$501,250
Option Awards$2,389,544
Salary$668,333
Stock Awards$2,277,460
Other$6,180
Total$5,842,767

Higgins received $2.4M in option awards, accounting for 41% of the total pay in 2020.

Higgins also received $501.3K in non-equity incentive plan, $668.3K in salary, $2.3M in stock awards and $6.2K in other compensation.

Rankings

In 2020, John L. Higgins' compensation ranked 1,813th out of 13,090 executives tracked by ExecPay. In other words, Higgins earned more than 86.1% of executives.

ClassificationRankingPercentile
All
1,813
out of 13,090
86th
Division
Manufacturing
698
out of 5,618
88th
Major group
Chemicals And Allied Products
250
out of 2,251
89th
Industry group
Drugs
209
out of 1,951
89th
Industry
Pharmaceutical Preparations
148
out of 1,456
90th
Source: SEC filing on April 22, 2022.

Higgins' colleagues

We found three more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2020.

2020

Matthew Foehr

Ligand Pharmaceuticals

Chief Operating Officer

2020

Matthew Korenberg

Ligand Pharmaceuticals

Chief Financial Officer

2020

Charles Berkman

Ligand Pharmaceuticals

General Counsel

News

You may also like